Post-operative Crohn's Endoscopic Recurrence Study

Post-Operative Crohn's Disease Endoscopic Recurrence POCER Study: Endoscopic Guided Therapeutic Intervention & Determination of Cause

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00989560

Acronym

POCER

Enrollment

175

Registered

2009-10-05

Start date

2009-08-31

Completion date

2013-04-30

Last updated

2014-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

Brief summary

This randomised, controlled study aims to evaluate the impact of endoscopic assessment, and adjustment of therapy, after surgery in patients with Crohn's disease. The primary endpoint is the severity of endoscopic recurrence. In addition, tissue will be collected for microbiological and immunological analysis.

Interventions

PROCEDUREendoscopy

patients receive best treatment and care with an additional endoscopy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* clinical diagnosis of Crohn's and proven history of disease * patient undergone surgical resection with creation of a primary anastomosis

Exclusion criteria

* endoscopically inaccessible anastomosis by standard colonoscopy * presence of an end stoma * pregnancy * suspected perforation of the gastrointestinal tract * presence of certain unsuitable comorbidities

Design outcomes

Primary

Measure	Time frame
Endoscopic recurrence of disease	18 months

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026